 We recently published a report on seven AI healthcare stocks noting that six were the result of recent IPOs. Of those, two are involved in drug discovery. Weve written extensively about how machine learning and computational chemistry are speeding up the drug development process and decreasing the likelihood that drugs will fail. Its all about taking an incredibly large amount of big data and turning it into insights. Today, were going to talk about another company that uses AI for drug discovery and just filed for an IPO - Lantern Pharma. About Lantern Pharma Founded in 2013, Texan startup Lantern 